A: Meiotic recombination protein DMC1/LIM15 homolog B: Meiotic recombination protein DMC1/LIM15 homolog C: Breast cancer type 2 susceptibility protein D: Breast cancer type 2 susceptibility protein ヘテロ分子
A: Meiotic recombination protein DMC1/LIM15 homolog B: Meiotic recombination protein DMC1/LIM15 homolog C: Breast cancer type 2 susceptibility protein D: Breast cancer type 2 susceptibility protein ヘテロ分子
A: Meiotic recombination protein DMC1/LIM15 homolog B: Meiotic recombination protein DMC1/LIM15 homolog C: Breast cancer type 2 susceptibility protein D: Breast cancer type 2 susceptibility protein ヘテロ分子
A: Meiotic recombination protein DMC1/LIM15 homolog B: Meiotic recombination protein DMC1/LIM15 homolog C: Breast cancer type 2 susceptibility protein D: Breast cancer type 2 susceptibility protein ヘテロ分子
A: Meiotic recombination protein DMC1/LIM15 homolog B: Meiotic recombination protein DMC1/LIM15 homolog C: Breast cancer type 2 susceptibility protein D: Breast cancer type 2 susceptibility protein ヘテロ分子
登録者が定義した集合体
根拠: gel filtration, A dimer is observed in the asymmetric unit, which is assembled into a ring-shaped octamer using the crystallographic symmetries. Size Exclusion Chromatography coupled to Multi- ...根拠: gel filtration, A dimer is observed in the asymmetric unit, which is assembled into a ring-shaped octamer using the crystallographic symmetries. Size Exclusion Chromatography coupled to Multi-Angle Light Scattering also shows that DMC1 bound to PhePP assembles into an octamer in solution.